XML 331 R46.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Employee benefits: variable compensation
12 Months Ended
Dec. 31, 2019
Disclosure Equity Participation And Other Compensation Plans [Line Items]  
Employee benefits: variable compensation [text block]

Note 30 Employee benefits: variable compensation

a) Plans offered

The Group has several share-based and other compensation plans that align the interests of Group Executive Board (GEB) members and other employees with the interests of investors. These compensation plans are also designed to meet regulatory requirements. The most significant compensation plans are described below.

Refer to Note 1a item 6 for a description of the accounting policy related to share-based and other deferred compensation plans

Mandatory deferred compensation plans

Equity Ownership Plan (EOP)

The EOP is a mandatory deferred share-based compensation plan for all employees with total annual compensation greater than USD / CHF 300,000. Starting with performance year 2019, GEB members, Group Managing Directors (GMDs) and Vice Chairs receive Long-Term Incentive Plan (LTIP) awards instead of EOP.

EOP awards granted to GEB members and GMDs in 2019 and prior years, as well as EOP awards granted to certain other employees, will only vest if both Group and business division performance conditions are met. For awards granted in 2019 and 2020, related to the performance years 2018 and 2019, respectively, the Group performance condition is based on the average reported return on common equity tier 1 capital (RoCET1). For awards granted in 2018 and before, the Group performance condition is based on the average adjusted return on tangible equity (RoTE) excluding deferred tax assets over the performance period. Business division performance is measured on the basis of their average adjusted return on attributed equity (RoAE). For Corporate Center employees, it is measured on the basis of the average operating businesses’ adjusted RoAE.

Certain awards, such as replacement awards issued outside the normal performance year cycle, may take the form of deferred cash under the EOP plan rules.

Notional shares represent a promise to receive UBS shares at vesting and do not carry voting rights during the vesting period. Awards granted generally carry a dividend equivalent that may be paid in notional shares or cash and that vests on the same terms and conditions as the awards. However, starting with awards granted in 2018 for the performance year 2017, European Banking Authority guidelines do not permit individuals who are deemed to be Material Risk Takers (MRTs) to receive dividend or interest payments on instruments awarded as deferred variable compensation. Where dividend payments are not permitted, the grant price of the EOP award is adjusted for the expected dividend yield over the vesting period to reflect the fair value of the non-dividend-bearing award.

Awards are settled by delivering UBS shares at vesting, except in jurisdictions where this is not permitted for legal or tax reasons. EOP awards generally vest in equal installments after two and three years following the granting of such awards. Awards granted to GEB members in 2019 and prior years generally vest after three, four and five years. The awards are generally forfeitable upon, among other circumstances, voluntary termination of employment with UBS.

Long-Term Incentive Plan

The LTIP is a mandatory deferred share-based compensation plan for senior leaders of the Group (i.e., GEB members, GMDs and Vice Chairs). LTIP awards are granted for the first time in 2020 as part of the performance award pool for 2019.

The final number of notional shares delivered at vesting depends on two equally weighted performance metrics: average reported return on CET1 capital (RoCET1) and relative total shareholder return (rTSR), which measures UBS's total shareholder return against an index consisting of global systemically important banks as determined by the Financial Stability Board. These performance metrics are separately valued as of the date of grant and (re-)assessed over a three-year performance period starting in the year of grant. For both metrics there is a threshold level, which would result in a 33% payout, and a maximum level, which would result in a 100% payout. Any performance between the threshold and the maximum level would result in a linear payout between 33% and 100%.

The final number of shares as determined at the end of the three-year performance period will vest in three equal installments in each of the three years following the performance period for GEB members, and cliff-vest in the first year following the performance period for GMDs and Vice Chairs. The awards are generally forfeitable upon, among other circumstances, voluntary termination of employment with UBS.

In general, the form of the equity awards (notional shares), the entitlement to dividend equivalents and the settlement method is the same as for EOP awards.

Deferred Contingent Capital Plan (DCCP)

The DCCP is a mandatory deferred compensation plan for all employees with total annual compensation greater than USD / CHF 300,000.

DCCP awards take the form of notional additional tier 1 (AT1) capital instruments, which, at the discretion of UBS, can be settled in either a cash payment or a perpetual, marketable AT1 capital instrument. DCCP awards vest in full after five years, and up to seven years for UK senior management functions, unless there is a trigger event.

Awards are forfeited if a viability event occurs, i.e., if FINMA notifies the firm in writing that the DCCP awards must be written down to prevent an insolvency, bankruptcy or failure of UBS, or if UBS receives a commitment of extraordinary support from the public sector that is necessary to prevent such an event. Additionally, they are also written down if the Group’s common equity tier 1 capital ratio falls below 10% for GEB members and below 7% for all other employees. As an additional performance condition, GEB members forfeit 20% of their award for each loss-making year during the vesting period.

Interest payments on DCCP awards are paid at the discretion of UBS. Where interest payments are not permitted, such as for MRTs, the DCCP award reflects the fair value of the granted non-interest-bearing award.

The awards are generally forfeitable upon, among other circumstances, voluntary termination of employment with UBS.

Asset Management EOP

In order to align deferred compensation of certain Asset Management employees with the performance of the investment funds they manage, awards are granted to such employees in the form of cash-settled notional investment funds. The amount delivered depends on the value of the underlying investment funds at the time of vesting. The awards are generally forfeitable upon, among other circumstances, voluntary termination of employment with UBS.

Financial advisor variable compensation

In line with market practice for US wealth management businesses, the compensation for US financial advisors in Global Wealth Management is comprised of production payout and deferred compensation awards. Production payout is primarily based on compensable revenue and is paid monthly.

Financial advisors may also qualify for deferred compensation awards, which generally vest over a six-year period. The awards are based on strategic performance measures, including production, length of service with the firm and net new business. Production payout rates and deferred compensation awards may be reduced for, among other things, errors, negligence or carelessness, or a failure to comply with the firm’s rules, standards, practices and policies or applicable laws and regulations.

Strategic objective awards

Strategic objective awards are deferred compensation awards based on strategic performance measures, including production, length of service with the firm and net new business. These awards are granted in the form of both deferred share-based and deferred cash-based awards, with a vesting period of up to six years.

Other compensation plans

Equity Plus Plan (Equity Plus)

Equity Plus is a voluntary share-based compensation plan that provides eligible employees with the opportunity to purchase UBS shares at market value and receive one notional share for every three shares purchased, up to a maximum annual limit. Share purchases may be made annually from the performance award and/or monthly through deductions from salary. If the shares purchased are held until three years from the start of the associated plan year and, in general, if the employee remains employed by UBS, the notional shares vest. Employees are entitled to receive a dividend equivalent which may be paid in notional shares and/or cash.

Role-based allowances (RBA)

Certain employees of legal entities regulated in the EU may receive an RBA in addition to their base salary. This allowance reflects the market value of a specific role and is fixed, non-forfeitable compensation. Unlike salary, an RBA is paid only as long as the employee is in such a role. RBA consist of a cash portion and, where applicable, a blocked UBS share award. Such shares will be unblocked in equal installments after two and three years. The compensation expense is recognized in the year of grant.

Discontinued deferred compensation plans

The following plans have been discontinued.

Key Employee Stock Appreciation Rights Plan (KESAP) and Key Employee Stock Option Plan (KESOP)

Until 2009, certain key and high-potential employees were granted discretionary share-settled stock appreciation rights (SARs) or options on UBS shares with a strike price not less than the market value of a UBS share on the date of grant. SARs gave employees the right to receive a number of UBS shares equal to the increase in market price of the UBS share between the grant date and the exercise date. One option entitled the holder to acquire one registered UBS share at the option’s strike price. SARs and options were settled by delivering UBS shares, except in jurisdictions where this was not permitted for legal reasons. All unexercised options and stock appreciation rights under these awards expired in 2019.

PartnerPlus

Through performance year 2016, financial advisor strategic objective awards were partly granted under the PartnerPlus deferred cash plan. In addition to such granted awards (UBS company contributions), participants were allowed to voluntarily contribute additional amounts otherwise payable as production payout up to a certain percentage, which vested upon contribution. Company contributions and voluntary contributions were credited with interest in accordance with the terms of the plan. Rather than being credited with interest, a participant could elect to have voluntary contributions, along with vested company contributions, credited with notional earnings based on the performance of various mutual funds. Company contributions and interest on both company and voluntary contributions ratably vest in 20% installments six to 10 years following grant date. Company contributions and interest on notional earnings on both company and voluntary contributions are forfeitable under certain circumstances.

GrowthPlus

GrowthPlus is a compensation plan for selected financial advisors whose revenue production and length of service exceeded defined thresholds from 2010 to 2017. Awards were granted in 2010, 2011, 2015 and 2018. The awards are cash-based and are distributed over seven years, with the exception of 2018 awards, which are distributed over five years.

Share delivery obligations

Share delivery obligations related to employee share-based compensation awards were 156 million shares as of 31 December 2019 (31 December 2018: 146 million shares). Share delivery obligations are calculated on the basis of undistributed notional share awards, options and stock appreciation rights, taking applicable performance conditions into account.

As of 31 December 2019, UBS held 125 million treasury shares (31 December 2018: 118 million) that were available to satisfy share delivery obligations. Treasury shares held are delivered to employees at exercise or vesting.

b) Effect on the income statement

Effect on the income statement for the financial year and future periods

The table below provides information about compensation expenses related to total variable compensation, including financial advisor variable compensation, that were recognized in the financial year ended 31 December 2019, as well as expenses that were deferred and will be recognized in the income statement for 2020 and later. The majority of expenses deferred to 2020 and later that are related to the performance year 2019 relates to awards granted in February 2020. The total unamortized compensation expense for unvested share-based awards granted up to 31 December 2019 will be recognized in future periods over a weighted average period of 2.4 years.

Variable compensation including financial advisor variable compensation
Expenses recognized in 2019Expenses deferred to 2020 and later1
USD millionRelated to the performance year 2019Related to prior performance yearsTotalRelated to the performance year 2019Related to prior performance yearsTotal
Non-deferred cash 1,894 (26) 1,868 0 0 0
Deferred compensation awards 299 588 887 429 608 1,036
of which: Equity Ownership Plan 122 300 422 205 219 424
of which: Deferred Contingent Capital Plan 113 262 375 173 365 538
of which: Long-Term Incentive Plan 39 0 39 25 0 25
of which: Asset Management EOP 25 26 51 26 23 49
Total variable compensation – performance awards 2,193 562 2,755 429 608 1,036
Replacement payments 5 51 56 44 30 75
Forfeiture credits 0 (86) (86) 0 0 0
Severance payments 125 0 125 0 0 0
Retention plan and other payments 28 28 56 23 29 52
Deferred Contingent Capital Plan: interest expense 0 94 94 50 172 222
Total variable compensation – other 159 88 246 117 232 349
Financial advisor variable compensation 3,233 268 3,501 197 710 907
of which: non-deferred cash 3,064 0 3,064 0 0 0
of which: deferred share-based awards 57 48 106 54 130 183
of which: deferred cash-based awards 112 219 331 144 580 724
Compensation commitments with recruited financial advisors2 32 510 542 350 1,617 1,967
Total financial advisor variable compensation 3,265 778 4,043 548 2,327 2,874
Total variable compensation including FA variable compensation 5,617 1,428 7,0453 1,093 3,166 4,259
1 Estimate as of 31 December 2019. Actual amounts to be expensed in future periods may vary, e.g., due to forfeiture of awards. 2 Reflects expenses related to compensation commitments with financial advisors entered into at the time of recruitment that are subject to vesting requirements. Amounts reflected as deferred expenses represent the maximum deferred exposure as of the balance sheet date. 3 Includes USD 610 million in expenses related to share-based compensation (performance awards: USD 461 million; other variable compensation: USD 43 million; financial advisor compensation: USD 106 million). A further USD 61 million in expenses related to share-based compensation was recognized within other expense categories included in Note 6 (salaries: USD 10 million, related to role-based allowances; social security: USD 25 million; other personnel expenses: USD 27 million related to the Equity Plus Plan). Total personnel expense related to share-based equity-settled compensation excluding social security was USD 619 million.

Variable compensation including financial advisor variable compensation (continued)
Expenses recognized in 2018Expenses deferred to 2019 and later1
USD millionRelated to the performance year 2018Related to prior performance yearsTotalRelated to the performance year 2018Related to prior performance yearsTotal
Non-deferred cash 2,089 (32) 2,057 0 0 0
Deferred compensation awards 373 565 938 585 653 1,238
of which: Equity Ownership Plan 217 309 526 325 244 570
of which: Deferred Contingent Capital Plan 131 226 357 238 382 620
of which: Asset Management EOP 25 28 53 22 26 48
of which: other performance awards 0 2 2 0 1 1
Total variable compensation – performance awards 2,461 534 2,995 585 653 1,238
Replacement payments 7 64 72 60 41 102
Forfeiture credits 0 (136) (136) 0 0 0
Severance payments 123 0 123 0 0 0
Retention plan and other payments 33 33 66 24 33 57
Deferred Contingent Capital Plan: interest expense 0 119 119 96 195 291
Total variable compensation – other 162 80 243 180 269 450
Financial advisor variable compensation 3,233 237 3,470 128 639 767
of which: non-deferred cash 3,089 0 3,089 0 0 0
of which: deferred share-based awards 51 44 95 52 131 183
of which: deferred cash-based awards 93 193 286 76 507 584
Compensation commitments with recruited financial advisors2 33 551 584 357 1,883 2,240
Total financial advisor variable compensation 3,266 789 4,054 484 2,522 3,006
Total variable compensation including FA variable compensation 5,889 1,403 7,2923 1,250 3,444 4,694
1 Estimate as of 31 December 2018. Actual amounts expensed may vary, e.g., due to forfeiture of awards. 2 Reflects expenses related to compensation commitments with financial advisors entered into at the time of recruitment that are subject to vesting requirements. Amounts reflected as deferred expenses represent the maximum deferred exposure as of the balance sheet date. 3 Includes USD 634 million in expenses related to share-based compensation (performance awards: USD 526 million; other variable compensation: USD 12 million; financial advisor compensation: USD 95 million). A further USD 49 million in expenses related to share-based compensation was recognized within other expense categories included in Note 6 (salaries: USD 15 million, related to role-based allowances; social security: USD 8 million; other personnel expenses: USD 26 million, related to the Equity Plus Plan). Total personnel expense related to share-based equity-settled compensation excluding social security was USD 676 million.

Variable compensation including financial advisor variable compensation (continued)
Expenses recognized in 2017Expenses deferred to 2018 and later1
USD millionRelated to the performance year 2017Related to prior performance yearsTotalRelated to the performance year 2017Related to prior performance yearsTotal
Non-deferred cash 2,088 (25) 2,062 0 0 0
Deferred compensation awards 399 689 1,088 594 697 1,291
of which: Equity Ownership Plan 239 344 583 329 291 620
of which: Deferred Contingent Capital Plan 135 310 444 238 376 614
of which: Asset Management EOP 25 32 57 27 27 54
of which: other performance awards 0 4 4 0 3 3
Total variable compensation – performance awards 2,487 664 3,151 594 697 1,291
Replacement payments 13 59 72 86 44 130
Forfeiture credits 0 (107) (107) 0 0 0
Severance payments 113 0 113 0 0 0
Retention plan and other payments 25 38 63 30 33 63
Deferred Contingent Capital Plan: interest expense 0 111 111 80 222 301
Total variable compensation – other 151 101 252 196 298 494
Financial advisor variable compensation 3,050 260 3,310 156 795 951
of which: non-deferred cash 2,891 0 2,891 0 0 0
of which: deferred share-based awards 54 48 102 70 121 191
of which: deferred cash-based awards 104 212 316 86 674 760
Compensation commitments with recruited financial advisors2 31 723 754 369 2,058 2,428
Total financial advisor variable compensation 3,080 984 4,064 526 2,853 3,379
Total variable compensation including FA variable compensation 5,718 1,749 7,4673 1,316 3,848 5,164
1 Estimate as of 31 December 2017. Actual amounts expensed may vary, e.g., due to forfeiture of awards. 2 Reflects expenses related to compensation commitments with financial advisors entered into at the time of recruitment that are subject to vesting requirements. Amounts reflected as deferred expenses represent the maximum deferred exposure as of the balance sheet date. 3 Includes USD 711 million in expenses related to share-based compensation (performance awards: USD 583 million; other variable compensation: USD 26 million; financial advisor compensation: USD 102 million). A further USD 101 million in expenses related to share-based compensation was recognized within other expense categories included in Note 6 (salaries: USD 25 million, related to role-based allowances; social security: USD 51 million; other personnel expenses: USD 25 million, related to the Equity Plus Plan). Total personnel expense related to share-based equity-settled compensation excluding social security was USD 735 million.

c) Outstanding share-based compensation awards

Share and performance share awards

Movements in outstanding share-based awards under the EOP during 2019 and 2018 are provided in the table below.

Movements in outstanding share-based compensation awards
Number of shares 2019Weighted averagegrant date fair value(USD)Number of shares 2018Weighted averagegrant date fair value(USD)
Outstanding, at the beginning of the year 146,845,027 16 162,835,713 15
Awarded during the year 77,641,909 11 58,329,398 17
Distributed during the year (61,152,200) 13 (67,696,099) 15
Forfeited during the year (7,269,974) 14 (6,623,984) 16
Outstanding, at the end of the year 156,064,763 14 146,845,027 16
of which: shares vested for accounting purposes 79,486,447 66,850,562

The total carrying amount of the liability related to cash-settled share-based awards as of 31 December 2019 and 31 December 2018 was USD 34 million and USD 39 million, respectively.

Option awards

No option awards have been granted since 2009. All remaining options expired in the year 2019. The table below provides information about movements in outstanding option awards during 2019 and 2018. As these awards are Swiss franc-denominated, weighted average exercise prices are presented in Swiss francs.

Movements in outstanding option awards
Number of options 2019Weighted averageexercise price (CHF)Number of options 2018Weighted averageexercise price (CHF)
Outstanding, at the beginning of the year 6,567,592 14 32,583,168 25
Exercised during the year1 (2,818,070) 10 (1,813,583) 12
Forfeited during the year (512) 16 (19,752) 23
Expired unexercised (3,749,010) 16 (24,182,241) 29
Outstanding, at the end of the year 0n/a 6,567,592 14
Exercisable, at the end of the year 0n/a 6,567,592 14
1 The weighted average share price upon option exercise was CHF 12.69 in 2019 (2018: CHF 16.22), resulting in an intrinsic value of CHF 7 million of options exercised during 2019 (2018: CHF 7 million).

SAR awards

No SAR awards have been granted since 2009. All remaining SARs expired in the year 2019. The table below provides information about movements in outstanding SAR awards during 2019 and 2018. As these awards are Swiss franc-denominated, weighted average exercise prices are presented in Swiss francs.

Movements in outstanding SAR awards
Number of SARs 2019Weighted average exercise price (CHF)Number of SARs 2018Weighted average exercise price (CHF)
Outstanding, at the beginning of the year 5,965,769 12 8,513,415 12
Exercised during the year1 (5,381,259) 11 (2,490,146) 11
Forfeited during the year 0 0 (11,000) 13
Expired unexercised (584,510) 16 (46,500) 12
Outstanding, at the end of the year 0n/a 5,965,769 12
Exercisable, at the end of the year 0n/a 5,965,769 12
1 The weighted average share price upon exercise of SARs was CHF 12.71 in 2019 (2018: CHF 16.15), resulting in an intrinsic value of CHF 7 million of SARs exercised during 2019 (2018: CHF 12 million).

d) Valuation

UBS share awards

UBS measures compensation expense based on the average market price of the UBS share on the grant date as quoted on the SIX Swiss Exchange, taking into consideration post-vesting sale and hedge restrictions, non-vesting conditions and market conditions, where applicable. The fair value of the share awards subject to post-vesting sale and hedge restrictions is discounted on the basis of the duration of the post-vesting restriction and is referenced to the cost of purchasing an at-the-money European put option for the term of the transfer restriction. The weighted average discount for share and performance share awards granted during 2019 was approximately 22.6% (2018: 18.0%) of the market price of the UBS share. The grant date fair value of notional shares without dividend entitlements also includes a deduction for the present value of future expected dividends to be paid between the grant date and distribution.

UBS AG  
Disclosure Equity Participation And Other Compensation Plans [Line Items]  
Employee benefits: variable compensation [text block]

Note 30 Employee benefits: variable compensation

a) Plans offered

UBS has several share-based and other compensation plans that align the interests of Group Executive Board (GEB) members and other employees with the interests of investors. These compensation plans are also designed to meet regulatory requirements. The most significant compensation plans are described below.

For the majority of variable compensation awards granted under such plans to employees of UBS AG, the grantor entity is UBS Group AG. Expenses associated with these awards are charged by UBS Group AG to UBS AG. For the purpose of this Note, references to shares refer to UBS Group AG shares.

Refer to Note 1a item 6 for a description of the accounting policy related to share-based and other deferred compensation plans

Mandatory deferred compensation plans

Equity Ownership Plan (EOP)

The EOP is a mandatory deferred share-based compensation plan for all employees with total annual compensation greater than USD / CHF 300,000. Starting with performance year 2019, GEB members, Group Managing Directors (GMDs) and Vice Chairs receive Long-Term Incentive Plan (LTIP) awards instead of EOP.

EOP awards granted to GEB members and GMDs in 2019 and prior years, as well as EOP awards granted to certain other employees, will only vest if both Group and business division performance conditions are met. For awards granted in 2019 and 2020, related to the performance years 2018 and 2019, respectively, the Group performance condition is based on the average reported return on common equity tier 1 capital (RoCET1). For awards granted in 2018 and before, the Group performance condition is based on the average adjusted return on tangible equity (RoTE) excluding deferred tax assets over the performance period. Business division performance is measured on the basis of their average adjusted return on attributed equity (RoAE). For Corporate Center employees, it is measured on the basis of the average operating businesses’ adjusted RoAE.

Certain awards, such as replacement awards issued outside the normal performance year cycle, may take the form of deferred cash under the EOP plan rules.

Notional shares represent a promise to receive UBS shares at vesting and do not carry voting rights during the vesting period. Awards granted generally carry a dividend equivalent that may be paid in notional shares or cash and that vests on the same terms and conditions as the awards. However, starting with awards granted in 2018 for the performance year 2017, European Banking Authority guidelines do not permit individuals who are deemed to be Material Risk Takers (MRTs) to receive dividend or interest payments on instruments awarded as deferred variable compensation. Where dividend payments are not permitted, the grant price of the EOP award is adjusted for the expected dividend yield over the vesting period to reflect the fair value of the non-dividend-bearing award.

Awards are settled by delivering UBS shares at vesting, except in jurisdictions where this is not permitted for legal or tax reasons. EOP awards generally vest in equal installments after two and three years following the granting of such awards. Awards granted to GEB members in 2019 and prior years generally vest after three, four and five years. The awards are generally forfeitable upon, among other circumstances, voluntary termination of employment with UBS.

Long-Term Incentive Plan

The LTIP is a mandatory deferred share-based compensation plan for senior leaders of the Group (i.e., GEB members, GMDs and Vice Chairs). LTIP awards are granted for the first time in 2020 as part of the performance award pool for 2019.

The final number of notional shares delivered at vesting depends on two equally weighted performance metrics: average reported return on CET1 capital (RoCET1) and relative total shareholder return (rTSR), which measures UBS's total shareholder return against an index consisting of global systemically important banks as determined by the Financial Stability Board. These performance metrics are separately valued as of the date of grant and (re-)assessed over a three-year performance period starting in the year of grant. For both metrics there is a threshold level, which would result in a 33% payout, and a maximum level, which would result in a 100% payout. Any performance between the threshold and the maximum level would result in a linear payout between 33% and 100%.

The final number of shares as determined at the end of the three-year performance period will vest in three equal installments in each of the three years following the performance period for GEB members, and cliff-vest in the first year following the performance period for GMDs and Vice Chairs. The awards are generally forfeitable upon, among other circumstances, voluntary termination of employment with UBS.

In general, the form of the equity awards (notional shares), the entitlement to dividend equivalents and the settlement method is the same as for EOP awards.

Deferred Contingent Capital Plan (DCCP)

The DCCP is a mandatory deferred compensation plan for all employees with total annual compensation greater than USD / CHF 300,000.

DCCP awards take the form of notional additional tier 1 (AT1) capital instruments, which, at the discretion of UBS, can be settled in either a cash payment or a perpetual, marketable AT1 capital instrument. DCCP awards vest in full after five years, and up to seven years for UK senior management functions, unless there is a trigger event.

Awards are forfeited if a viability event occurs, i.e., if FINMA notifies the firm in writing that the DCCP awards must be written down to prevent an insolvency, bankruptcy or failure of UBS, or if UBS receives a commitment of extraordinary support from the public sector that is necessary to prevent such an event. Additionally, they are also written down if the Group’s common equity tier 1 capital ratio falls below 10% for GEB members and below 7% for all other employees. As an additional performance condition, GEB members forfeit 20% of their award for each loss-making year during the vesting period.

Interest payments on DCCP awards are paid at the discretion of UBS. Where interest payments are not permitted, such as for MRTs, the DCCP award reflects the fair value of the granted non-interest-bearing award.

The awards are generally forfeitable upon, among other circumstances, voluntary termination of employment with UBS.

Asset Management EOP

In order to align deferred compensation of certain Asset Management employees with the performance of the investment funds they manage, awards are granted to such employees in the form of cash-settled notional investment funds. The amount delivered depends on the value of the underlying investment funds at the time of vesting. The awards are generally forfeitable upon, among other circumstances, voluntary termination of employment with UBS.

Financial advisor variable compensation

In line with market practice for US wealth management businesses, the compensation for US financial advisors in Global Wealth Management is comprised of production payout and deferred compensation awards. Production payout is primarily based on compensable revenue and is paid monthly.

Financial advisors may also qualify for deferred compensation awards, which generally vest over a six-year period. The awards are based on strategic performance measures, including production, length of service with the firm and net new business. Production payout rates and deferred compensation awards may be reduced for, among other things, errors, negligence or carelessness, or a failure to comply with the firm’s rules, standards, practices and policies or applicable laws and regulations.

Strategic objective awards

Strategic objective awards are deferred compensation awards based on strategic performance measures, including production, length of service with the firm and net new business. These awards are granted in the form of both deferred share-based and deferred cash-based awards, with a vesting period of up to six years.

Other compensation plans

Equity Plus Plan (Equity Plus)

Equity Plus is a voluntary share-based compensation plan that provides eligible employees with the opportunity to purchase UBS shares at market value and receive one notional share for every three shares purchased, up to a maximum annual limit. Share purchases may be made annually from the performance award and/or monthly through deductions from salary. If the shares purchased are held until three years from the start of the associated plan year and, in general, if the employee remains employed by UBS, the notional shares vest. Employees are entitled to receive a dividend equivalent which may be paid in notional shares and/or cash.

Role-based allowances (RBA)

Certain employees of legal entities regulated in the EU may receive an RBA in addition to their base salary. This allowance reflects the market value of a specific role and is fixed, non-forfeitable compensation. Unlike salary, an RBA is paid only as long as the employee is in such a role. RBA consist of a cash portion and, where applicable, a blocked UBS share award. Such shares will be unblocked in equal installments after two and three years. The compensation expense is recognized in the year of grant.

Discontinued deferred compensation plans

The following plans have been discontinued.

Key Employee Stock Appreciation Rights Plan (KESAP) and Key Employee Stock Option Plan (KESOP)

Until 2009, certain key and high-potential employees were granted discretionary share-settled stock appreciation rights (SARs) or options on UBS shares with a strike price not less than the market value of a UBS share on the date of grant. SARs gave employees the right to receive a number of UBS shares equal to the increase in market price of the UBS share between the grant date and the exercise date. One option entitled the holder to acquire one registered UBS share at the option’s strike price. SARs and options were settled by delivering UBS shares, except in jurisdictions where this was not permitted for legal reasons. All unexercised options and stock appreciation rights under these awards expired in 2019.

PartnerPlus

Through performance year 2016, financial advisor strategic objective awards were partly granted under the PartnerPlus deferred cash plan. In addition to such granted awards (UBS company contributions), participants were allowed to voluntarily contribute additional amounts otherwise payable as production payout up to a certain percentage, which vested upon contribution. Company contributions and voluntary contributions were credited with interest in accordance with the terms of the plan. Rather than being credited with interest, a participant could elect to have voluntary contributions, along with vested company contributions, credited with notional earnings based on the performance of various mutual funds. Company contributions and interest on both company and voluntary contributions ratably vest in 20% installments six to 10 years following grant date. Company contributions and interest on notional earnings on both company and voluntary contributions are forfeitable under certain circumstances.

GrowthPlus

GrowthPlus is a compensation plan for selected financial advisors whose revenue production and length of service exceeded defined thresholds from 2010 to 2017. Awards were granted in 2010, 2011, 2015 and 2018. The awards are cash-based and are distributed over seven years, with the exception of 2018 awards, which are distributed over five years.

b) Effect on the income statement

Effect on the income statement for the financial year and future periods

The table below provides information about compensation expenses related to total variable compensation, including financial advisor variable compensation, that were recognized in the financial year ended 31 December 2019, as well as expenses that were deferred and will be recognized in the income statement for 2020 and later. The majority of expenses deferred to 2020 and later that are related to the performance year 2019 relates to awards granted in February 2020. The total unamortized compensation expense for unvested share-based awards granted up to 31 December 2019 will be recognized in future periods over a weighted average period of 2.4 years.

Variable compensation including financial advisor variable compensation
Expenses recognized in 2019Expenses deferred to 2020 and later1
USD millionRelated to the performance year 2019Related to prior performance yearsTotalRelated to the performance year 2019Related to prior performance yearsTotal
Non-deferred cash 1,706 (24) 1,682 0 0 0
Deferred compensation awards 287 576 863 413 592 1,005
of which: Equity Ownership Plan 115 294 410 198 213 412
of which: Deferred Contingent Capital Plan 109 256 365 166 356 521
of which: Long-Term Incentive Plan 38 0 38 23 0 23
of which: Asset Management EOP 25 26 51 26 23 49
Total variable compensation – performance awards 1,993 553 2,545 413 592 1,005
Replacement payments 5 49 55 43 30 73
Forfeiture credits 0 (84) (84) 0 0 0
Severance payments 110 0 110 0 0 0
Retention plan and other payments 24 27 52 22 29 51
Deferred Contingent Capital Plan: interest expense 0 93 93 50 169 219
Total variable compensation – other 140 85 225 115 228 343
Financial advisor variable compensation 3,233 268 3,501 197 710 907
of which: non-deferred cash 3,064 0 3,064 0 0 0
of which: deferred share-based awards 57 48 106 54 130 183
of which: deferred cash-based awards 112 219 331 144 580 724
Compensation commitments with recruited financial advisors2 32 510 542 350 1,617 1,967
Total financial advisor variable compensation 3,265 778 4,043 548 2,327 2,874
Total variable compensation including FA variable compensation 5,398 1,416 6,8143 1,076 3,146 4,222
1 Estimate as of 31 December 2019. Actual amounts to be expensed in future periods may vary, e.g., due to forfeiture of awards. 2 Reflects expenses related to compensation commitments with financial advisors entered into at the time of recruitment that are subject to vesting requirements. Amounts reflected as deferred expenses represent the maximum deferred exposure as of the balance sheet date. 3 Includes USD 595 million in expenses related to share-based compensation (performance awards: USD 448 million; other variable compensation: USD 42 million; financial advisor compensation: USD 106 million). A further USD 54 million in expenses related to share-based compensation was recognized within other expense categories included in Note 6 (salaries: USD 10 million, related to role-based allowances; social security: USD 23 million; other personnel expenses: USD 22 million related to the Equity Plus Plan).

Variable compensation including financial advisor variable compensation (continued)
Expenses recognized in 2018Expenses deferred to 2019 and later1
USD millionRelated to the performance year 2018Related to prior performance yearsTotalRelated to the performance year 2018Related to prior performance yearsTotal
Non-deferred cash 1,896 (26) 1,870 0 0 0
Deferred compensation awards 360 564 924 570 638 1,208
of which: Equity Ownership Plan 208 299 507 316 238 554
of which: Deferred Contingent Capital Plan 126 235 361 232 373 605
of which: Asset Management EOP 25 28 53 22 26 48
of which: other performance awards 0 2 2 0 1 1
Total variable compensation – performance awards 2,256 538 2,794 570 638 1,208
Replacement payments 7 61 68 58 40 99
Forfeiture credits 0 (136) (136) 0 0 0
Severance payments 106 0 106 0 0 0
Retention plan and other payments 31 33 64 23 33 56
Deferred Contingent Capital Plan: interest expense 0 116 116 96 191 288
Total variable compensation – other 144 75 220 178 264 442
Financial advisor variable compensation 3,233 237 3,470 128 639 767
of which: non-deferred cash 3,089 0 3,089 0 0 0
of which: deferred share-based awards 51 44 95 52 131 183
of which: deferred cash-based awards 93 193 286 76 507 584
Compensation commitments with recruited financial advisors2 33 551 584 357 1,883 2,240
Total financial advisor variable compensation 3,266 789 4,054 484 2,522 3,006
Total variable compensation including FA variable compensation 5,666 1,402 7,0683 1,233 3,424 4,656
1 Estimate as of 31 December 2018. Actual amounts expensed may vary, e.g., due to forfeiture of awards. 2 Reflects expenses related to compensation commitments with financial advisors entered into at the time of recruitment that are subject to vesting requirements. Amounts reflected as deferred expenses represent the maximum deferred exposure as of the balance sheet date. 3 Includes USD 612 million in expenses related to share-based compensation (performance awards: USD 507 million; other variable compensation: USD 10 million; financial advisor compensation: USD 95 million). A further USD 44 million in expenses related to share-based compensation was recognized within other expense categories included in Note 6 (salaries: USD 15 million, related to role-based allowances; social security: USD 7 million; other personnel expenses: USD 22 million, related to the Equity Plus Plan).

Variable compensation including financial advisor variable compensation (continued)
Expenses recognized in 2017Expenses deferred to 2018 and later1
USD millionRelated to the performance year 2017Related to prior performance yearsTotalRelated to the performance year 2017Related to prior performance yearsTotal
Non-deferred cash 1,982 (24) 1,958 0 0 0
Deferred compensation awards 392 704 1,096 589 685 1,274
of which: Equity Ownership Plan 235 364 599 322 286 608
of which: Deferred Contingent Capital Plan 132 304 436 240 369 609
of which: Asset Management EOP 25 32 57 27 27 54
of which: other performance awards 0 4 4 0 3 3
Total variable compensation – performance awards 2,373 680 3,054 589 685 1,274
Replacement payments 12 58 70 82 41 123
Forfeiture credits 0 (106) (106) 0 0 0
Severance payments 95 0 95 0 0 0
Retention plan and other payments 24 38 62 30 32 62
Deferred Contingent Capital Plan: interest expense 0 110 110 80 218 297
Total variable compensation – other 131 99 231 191 291 482
Financial advisor variable compensation 3,050 260 3,310 156 795 951
of which: non-deferred cash 2,891 0 2,891 0 0 0
of which: deferred share-based awards 54 48 102 70 121 191
of which: deferred cash-based awards 104 212 316 86 674 760
Compensation commitments with recruited financial advisors2 31 723 754 369 2,058 2,429
Total financial advisor variable compensation 3,080 984 4,064 526 2,853 3,379
Total variable compensation including FA variable compensation 5,585 1,764 7,3493 1,306 3,829 5,135
1 Estimate as of 31 December 2017. Actual amounts expensed may vary, e.g., due to forfeiture of awards. 2 Reflects expenses related to compensation commitments with financial advisors entered into at the time of recruitment that are subject to vesting requirements. Amounts reflected as deferred expenses represent the maximum deferred exposure as of the balance sheet date. 3 Includes USD 726 million in expenses related to share-based compensation (performance awards: USD 599 million; other variable compensation: USD 25 million; financial advisor compensation: USD 102 million). A further USD 97 million in expenses related to share-based compensation was recognized within other expense categories included in Note 6 (salaries: USD 25 million, related to role-based allowances; social security: USD 49 million; other personnel expenses: USD 23 million, related to the Equity Plus Plan).

c) Outstanding share-based compensation awards

Share and performance share awards

Movements in outstanding share-based awards under the EOP during 2019 and 2018 are provided in the table below.

The awards presented are granted by UBS AG, but are based on UBS Group AG shares.

Movements in outstanding share-based compensation awards
Number of shares2019Weighted average grant date fair value (USD)Number of shares2018Weighted average grant date fair value (USD)
Outstanding, at the beginning of the year 201,793 15 404,720 15
Awarded during the year 29,092 11 26,005 13
Distributed during the year (140,441) 14 (228,932) 15
Forfeited during the year 0 0 0 0
Outstanding, at the end of the year 90,443 14 201,793 15
of which: shares vested for accounting purposes 56,492 133,225

The total carrying amount of the liability related to cash-settled share-based awards as of 31 December 2019 and 31 December 2018 was USD 1 million and USD 2 million, respectively.

d) Valuation

UBS share awards

UBS measures compensation expense based on the average market price of the UBS share on the grant date as quoted on the SIX Swiss Exchange, taking into consideration post-vesting sale and hedge restrictions, non-vesting conditions and market conditions, where applicable. The fair value of the share awards subject to post-vesting sale and hedge restrictions is discounted on the basis of the duration of the post-vesting restriction and is referenced to the cost of purchasing an at-the-money European put option for the term of the transfer restriction. The weighted average discount for share and performance share awards granted during 2019 was approximately 22.6% (2018: 18.0%) of the market price of the UBS share. The grant date fair value of notional shares without dividend entitlements also includes a deduction for the present value of future expected dividends to be paid between the grant date and distribution.